Radiation damage and radioprotectants: new concepts in the era of molecular medicine.
暂无分享,去创建一个
[1] T. Stokke,et al. Overexpression of human OGG1 in mammalian cells decreases ultraviolet A induced mutagenesis. , 2008, Cancer letters.
[2] Olga Kovalchuk,et al. Radiation‐induced bystander effects in vivo are epigenetically regulated in a tissue‐specific manner , 2009, Environmental and molecular mutagenesis.
[3] K. Wu,et al. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. , 2005, Journal of the American Society of Nephrology : JASN.
[4] S. Lees-Miller,et al. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. , 2009, The Biochemical journal.
[5] J. Yarnold,et al. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] F. Killander,et al. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). , 2009, European journal of cancer.
[7] K. Kang,et al. Butin decreases oxidative stress-induced 8-hydroxy-2'-deoxyguanosine levels via activation of oxoguanine glycosylase 1. , 2009, Chemico-biological interactions.
[8] A. Finnegan,et al. Interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription in human monocytes. , 1997, Blood.
[9] Lujun Zhao,et al. Inhibition of the Tumor Necrosis Factor-α Pathway Is Radioprotective for the Lung , 2008, Clinical Cancer Research.
[10] D. Brooks,et al. Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis , 2005, Journal of Pharmacology and Experimental Therapeutics.
[11] F. Bootz,et al. Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis , 2009, Arthritis research & therapy.
[12] M. Kolb,et al. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. , 2005, American journal of respiratory and critical care medicine.
[13] T. Horie,et al. Transforming Growth Factor- β1 Induces Phenotypic Modulation of Human Lung Fibroblasts to Myofibroblast Through a c-Jun-NH2-Terminal Kinase-Dependent Pathway , 2001 .
[14] L. H. Gray,et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.
[15] Dingcai Cao,et al. Delayed Radioprotection by NFκB-Mediated Induction of Sod2 (MnSOD) in SA-NH Tumor Cells after Exposure to Clinically Used Thiol-Containing Drugs , 2004, Radiation research.
[16] W. Erl,et al. Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells , 1999 .
[17] R. Clough,et al. Plasma transforming growth factor β1 as a predictor of radiation pneumonitis , 1997 .
[18] J A Aguilera,et al. Effect of polyamine-induced compaction and aggregation of DNA on the formation of radiation-induced strand breaks: quantitative models for cellular radiation damage. , 1997, Radiation research.
[19] S. Dhein,et al. Peptides targeting gap junctional structures. , 2010, Current pharmaceutical design.
[20] E. Rosen,et al. Role of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protection , 2005, Oncogene.
[21] Young-Sun Kim,et al. Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1. , 2009, Cancer letters.
[22] D. Hallahan,et al. Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] H. Oku,et al. A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level. , 2002, European journal of pharmacology.
[24] J. Fowler. Review: total doses in fractionated radiotherapy--implications of new radiobiological data. , 1984, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[25] P Beck,et al. Overview of research on aircraft crew dosimetry during the last solar cycle. , 2009, Radiation protection dosimetry.
[26] E. Yang,et al. Clioquinol, a Cu(II)/Zn(II) Chelator, Inhibits Both Ubiquitination and Asparagine Hydroxylation of Hypoxia-inducible Factor-1α, Leading to Expression of Vascular Endothelial Growth Factor and Erythropoietin in Normoxic Cells* , 2006, Journal of Biological Chemistry.
[27] Gregor Jost,et al. Dicentric chromosomes and gamma-H2AX foci formation in lymphocytes of human blood samples exposed to a CT scanner: a direct comparison of dose response relationships. , 2009, Radiation protection dosimetry.
[28] Y. M. Lee,et al. Baicalein Induces Functional Hypoxia-Inducible Factor-1α and Angiogenesis , 2008, Molecular Pharmacology.
[29] M. Benderitter,et al. Pravastatin Limits Endothelial Activation after Irradiation and Decreases the Resulting Inflammatory and Thrombotic Responses , 2005, Radiation research.
[30] M. Koukourakis,et al. Amifostine: is there evidence of tumor protection? , 2003, Seminars in oncology.
[31] T. Girinsky. Effets des radiations ionisantes sur les parois vasculaires , 2000 .
[32] M. Kono,et al. Expression of pulmonary mRNA encoding ICAM-1, VCAM-1, and P-selectin following thoracic irradiation in mice. , 1999, Radiation medicine.
[33] H. Liber,et al. Partial deficiency of DNA-PKcs increases ionizing radiation-induced mutagenesis and telomere instability in human cells. , 2007, Cancer letters.
[34] A. El-Osta,et al. γH2AX: a sensitive molecular marker of DNA damage and repair , 2010, Leukemia.
[35] W. Gradishar,et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Christopher S Potten,et al. The intestinal epithelial stem cell. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[37] J. Wondergem,et al. Microarray analysis of gene expression profiles of cardiac myocytes and fibroblasts after mechanical stress, ionising or ultraviolet radiation , 2005, BMC Genomics.
[38] H. Yamamoto,et al. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. , 2001, American journal of respiratory cell and molecular biology.
[39] B. Halliwell,et al. Free Radicals and Antioxidants in the Year 2000: A Historical Look to the Future , 2000, Annals of the New York Academy of Sciences.
[40] D. Hallahan,et al. A new class of molecular targeted radioprotectors: GSK-3beta inhibitors. , 2010, International journal of radiation oncology, biology, physics.
[41] W. Dewey,et al. A dose response for radiation-induced intrachromosomal DNA rearrangements detected by inverse polymerase chain reaction. , 1999, Radiation research.
[42] Xianglin Shi,et al. Vanadate-induced Expression of Hypoxia-inducible Factor 1α and Vascular Endothelial Growth Factor through Phosphatidylinositol 3-Kinase/Akt Pathway and Reactive Oxygen Species* , 2002, The Journal of Biological Chemistry.
[43] J. Loscalzo,et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.
[44] Xiao Zhou,et al. Effects of adenovirus-mediated delivery of the human hepatocyte growth factor gene in experimental radiation-induced heart disease. , 2009, International journal of radiation oncology, biology, physics.
[45] M. Koukourakis,et al. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. , 2006, International journal of radiation oncology, biology, physics.
[46] J. Debus,et al. Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells , 2006, BMC Cancer.
[47] R. Ullrich,et al. Resveratrol Reduces Radiation-Induced Chromosome Aberration Frequencies in Mouse Bone Marrow Cells , 2008, Radiation research.
[48] Y. J. Wang,et al. Characteristics of rhVEGF Release from Topical Hydrogel Formulations , 2010, Pharmaceutical Research.
[49] Y. Song,et al. Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells. , 2010, Carcinogenesis.
[50] Yusuke Nakamura,et al. Analysis of gene-expression profiles after gamma irradiation of normal human fibroblasts. , 2006, International journal of radiation oncology, biology, physics.
[51] D. Geschwind,et al. Small Molecule Activation of Adaptive Gene Expression , 2008, Annals of the New York Academy of Sciences.
[52] D. Mottet,et al. CoCl2, a Chemical Inducer of Hypoxia‐Inducible Factor‐1, and Hypoxia Reduce Apoptotic Cell Death in Hepatoma Cell Line HepG2 , 2002, Annals of the New York Academy of Sciences.
[53] A. Azmi,et al. An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals , 2009, Molecular Cancer.
[54] E. Hall,et al. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.
[55] J. Molkentin,et al. Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. , 2007, American journal of physiology. Cell physiology.
[56] Yan Wang,et al. ER stress induced by ionising radiation in IEC-6 cells , 2010, International journal of radiation biology.
[57] D. Radzioch,et al. Protein kinase C inhibitors block the activation of macrophages by IFN-beta but not by IFN-gamma. , 1988, Journal of immunology.
[58] D. Green,et al. The BCL-2 family reunion. , 2010, Molecular cell.
[59] E. Gore. Celecoxib and radiation therapy in non-small-cell lung cancer. , 2004, Oncology.
[60] S. Nishimura. Mammalian Ogg1/Mmh gene plays a major role in repair of the 8-hydroxyguanine lesion in DNA. , 2001, Progress in nucleic acid research and molecular biology.
[61] G. Semenza,et al. Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.
[62] N. Chen,et al. Role and regulation of autophagy in cancer. , 2009, Biochimica et biophysica acta.
[63] N. Shigematsu,et al. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action. , 1995, Carcinogenesis.
[64] W. Morgan,et al. Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α , 2007 .
[65] K. Matsumoto,et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. , 1997, American journal of respiratory and critical care medicine.
[66] T. Sugimura,et al. Role of Parp-1 in suppressing spontaneous deletion mutation in the liver and brain of mice at adolescence and advanced age. , 2009, Mutation research.
[67] M. Dewhirst,et al. Radiation-induced hypoxia may perpetuate late normal tissue injury. , 2001, International journal of radiation oncology, biology, physics.
[68] M. Kawano,et al. Inhibitory effect of baicalein on IL‐6‐mediated signaling cascades in human myeloma cells , 2010, European journal of haematology.
[69] G. Semenza,et al. Regulation of gene expression by HIF-1. , 2006, Novartis Foundation symposium.
[70] Y. A. Minamishima,et al. A possible role for centrosome overduplication in radiation-induced cell death , 2000, Oncogene.
[71] J. Hanft,et al. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. , 2008, Journal of wound care.
[72] J. Hervé,et al. The Connexin Turnover, an Important Modulating Factor of the Level of Cell-to-Cell Junctional Communication: Comparison with Other Integral Membrane Proteins , 2007, Journal of Membrane Biology.
[73] M. Delivoria-Papadopoulos,et al. Alterations in oxygen transport following WR-2721. , 1984, International journal of radiation oncology, biology, physics.
[74] Otto Warburn,et al. THE METABOLISM OF TUMORS , 1931 .
[75] Sudipta Seal,et al. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[76] Shin Aoki,et al. Sodium orthovanadate inhibits p53-mediated apoptosis. , 2010, Cancer research.
[77] K. Sugimachi,et al. Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice , 2003, Gene Therapy.
[78] F. Mollinedo,et al. Novel Anti-Inflammatory Action of Edelfosine Lacking Toxicity with Protective Effect in Experimental Colitis , 2009, Journal of Pharmacology and Experimental Therapeutics.
[79] Yu Lin,et al. Additive Effect of TAK-491, a New Angiotensin Receptor Blocker, and Pioglitazone, in Reducing Myocardial Infarct Size , 2010, Cardiovascular Drugs and Therapy.
[80] D. McGuire,et al. Clinical Practice Guidelines for the Prevention and Treatment of Mucositis , 2007 .
[81] J. Bankson,et al. The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects , 2009, Molecular Cancer Therapeutics.
[82] M Blettner,et al. Is cancer risk of radiation workers larger than expected? , 2009, Occupational and Environmental Medicine.
[83] J. Damilakis,et al. Radiation dose to conceptus resulting from tangential breast irradiation. , 2003, International journal of radiation oncology, biology, physics.
[84] E. Gerner,et al. Inhibition of ionizing radiation recovery processes in polyamine-depleted Chinese hamster cells. , 1988, Cancer research.
[85] B. Brüne,et al. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. , 2003, Molecular biology of the cell.
[86] A. Fine,et al. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. , 1987, The Journal of biological chemistry.
[87] L. Kronberg,et al. Potent inhibition of gap junctional intercellular communication by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in BALB/c 3T3 cells. , 2004, Toxicology letters.
[88] I-Li Liu,et al. Hepatocyte growth factor gene therapy prevents radiation-induced liver damage. , 2005, World journal of gastroenterology.
[89] A. Forbes,et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease , 2001, Gut.
[90] David J Brenner,et al. Should We be Concerned About the Rapid Increase in CT Usage? , 2010, Reviews on environmental health.
[91] P. Okunieff,et al. Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation. , 2010, International journal of radiation oncology, biology, physics.
[92] R. Baskar. Emerging role of radiation induced bystander effects: Cell communications and carcinogenesis , 2010, Genome Integrity.
[93] Y. Ogawa,et al. Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector. , 2004, International journal of radiation oncology, biology, physics.
[94] Huichen Wang,et al. Histone H1 functions as a stimulatory factor in backup pathways of NHEJ , 2008, Nucleic acids research.
[95] E. Bump,et al. Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. , 1990, Pharmacology & therapeutics.
[96] L. Milas,et al. Antimutagenic effects of amifostine: clinical implications. , 1996, Seminars in oncology.
[97] N. Senzer,et al. A review of contusugene ladenovec (Advexin) p53 therapy. , 2009, Current opinion in molecular therapeutics.
[98] P. Rubin,et al. Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis. , 1994, International journal of radiation oncology, biology, physics.
[99] F. Roila,et al. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[100] T. Kishimoto,et al. Anti-interleukin 6 receptor antibody treatment in rheumatic disease , 2000, Annals of the rheumatic diseases.
[101] Bahram Parvin,et al. Targeted and nontargeted effects of ionizing radiation that impact genomic instability. , 2008, Cancer research.
[102] C. Swenberg,et al. Thiol WR-1065 and disulphide WR-33278, two metabolites of the drug ethyol (WR-2721), protect DNA against fast neutron-induced strand breakage. , 1997, International journal of radiation biology.
[103] C. Hsu,et al. Bronchoalveolar lavage and interstitial cells have different roles in radiation-induced lung injury , 2003, International journal of radiation biology.
[104] C. Swenberg,et al. Enhancement of topoisomerase I-mediated unwinding of supercoiled DNA by the radioprotector WR-33278. , 1990, Radiation research.
[105] Kebin Hu,et al. Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. , 2005, The American journal of pathology.
[106] A. Chanan-Khan,et al. Targeting the Bcl-2 , 2009, Current opinion in oncology.
[107] T. Mandal,et al. Radioprotection in mice following oral administration of WR-1065/PLGA nanoparticles , 2008, International journal of radiation biology.
[108] Shu-zheng Liu. Biological effects of low level exposures to ionizing radiation: Theory and practice , 2010, Human & experimental toxicology.
[109] A. Gillum,et al. Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. , 2002, Antisense & nucleic acid drug development.
[110] S. Colgan,et al. Mucosal protection by hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibition , 2008 .
[111] T. Kirkwood,et al. Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo. , 2003, Nucleic acids research.
[112] J. Bourhis,et al. Pravastatin Inhibits the Rho/CCN2/Extracellular Matrix Cascade in Human Fibrosis Explants and Improves Radiation-Induced Intestinal Fibrosis in Rats , 2007, Clinical Cancer Research.
[113] T. O’Brien,et al. Generation of antioxidant adenovirus gene transfer vectors encoding CuZnSOD, MnSOD, and catalase. , 2010, Methods in molecular biology.
[114] K. Kuwano,et al. Anti-Vascular Endothelial Growth Factor Gene Therapy Attenuates Lung Injury and Fibrosis in Mice1 , 2005, The Journal of Immunology.
[115] C. Daniels,et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. , 2004, The Journal of clinical investigation.
[116] Fabian Kiessling,et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis , 2005, The Journal of experimental medicine.
[117] R. Porcher,et al. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[118] David J. Chen,et al. Suppression of nonhomologous end joining repair by overexpression of HMGA2. , 2009, Cancer research.
[119] E. Hall,et al. Genomic instability and bystander effects induced by high-LET radiation , 2003, Oncogene.
[120] Phuong Chung,et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.
[121] P. Okunieff,et al. Circulating IL-6 as a predictor of radiation pneumonitis. , 2001, International journal of radiation oncology, biology, physics.
[122] W. Göhde,et al. Frequency of CD59 mutations induced in human-hamster hybrid A(L) cells by low-dose X-irradiation. , 2001, Mutation research.
[123] M. Lübbert,et al. Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancer-binding protein-α , 2005, Leukemia.
[124] J. Denekamp,et al. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. , 1984, British Journal of Cancer.
[125] David M. Thomas,et al. Imatinib therapy reduces radiation-induced pulmonary mast cell influx and delays lung disease in the mouse , 2010, International journal of radiation biology.
[126] P. Slijepcevic. The role of DNA damage response proteins at telomeres--an "integrative" model. , 2006, DNA repair.
[127] E. Noordijk,et al. Survival after Hodgkin lymphoma , 2009, Cancer.
[128] M. Koukourakis,et al. Radiation-induced autophagy in normal and cancer cells: Towards novel cytoprotection and radio-sensitization policies? , 2009, Autophagy.
[129] T. Massey,et al. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[130] Shin‐Sung Kang,et al. TGF‐β3 inhibits chondrogenesis of cultured chick leg bud mesenchymal cells via downregulation of connexin 43 and integrin β4 , 2008 .
[131] Bin Wang,et al. Anti-TNFA (TNF-α) Treatment Abrogates Radiation-Induced Changes in Vascular Density and Tissue Oxygenation , 2007 .
[132] J. M. Taylor,et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. , 2000, International journal of radiation biology.
[133] D Segretain,et al. A proposed role for ZO-1 in targeting connexin 43 gap junctions to the endocytic pathway. , 2004, Biochimie.
[134] James B. Mitchell,et al. Differential Radiation Protection of Salivary Glands versus Tumor by Tempol with Accompanying Tissue Assessment of Tempol by Magnetic Resonance Imaging , 2007, Clinical Cancer Research.
[135] B. Carnes,et al. Protective effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation within one day after birth. , 1985, Cancer research.
[136] I. Yeung,et al. Partial volume rat lung irradiation; assessment of early DNA damage in different lung regions and effect of radical scavengers. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[137] D. Gridley,et al. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[138] A. Giatromanolaki,et al. Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[139] B. Henderson,et al. Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. , 1986, Radiation research.
[140] Michael Bacher,et al. ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis* , 2005, Journal of Biological Chemistry.
[141] A. Nel,et al. The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes1 , 2000, The Journal of Immunology.
[142] A. Moon,et al. Both Platelet-Derived Growth Factor Receptor (PDGFR)-α and PDGFR-β Promote Murine Fibroblast Cell Migration , 2001 .
[143] O. Folkerts,et al. Human fibroblast growth factor 20 (FGF-20; CG53135-05): A novel cytoprotectant with radioprotective potential , 2005, International journal of radiation biology.
[144] N. Huda,et al. DNA Damage-Induced Phosphorylation of TRF2 Is Required for the Fast Pathway of DNA Double-Strand Break Repair , 2009, Molecular and Cellular Biology.
[145] P. Rubin,et al. ICAM-1 Induction in the Mouse CNS Following Irradiation , 1997, Brain, Behavior, and Immunity.
[146] D. Tait,et al. Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[147] J. Damborský,et al. Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast , 2007, Oncogene.
[148] Masashi Suzuki,et al. An FGF1:FGF2 chimeric growth factor exhibits universal FGF receptor specificity, enhanced stability and augmented activity useful for epithelial proliferation and radioprotection. , 2008, Biochimica et biophysica acta.
[149] J. Lefaix,et al. Unlike tenascin-X, tenascin-C is highly up-regulated in pig cutaneous and underlying muscle tissue developing fibrosis after necrosis induced by very high-dose gamma radiation. , 1998, Radiation research.
[150] U. Costabel,et al. Pentoxifylline Inhibits TNF- α Production from Human Alveolar Macrophages , 1999 .
[151] D. Su,et al. Up-regulation of Hypoxia Inducible Factor 1&agr; by Isoflurane in Hep3B Cells , 2006, Anesthesiology.
[152] L Sabatier,et al. Radiation-induced chromosome damage in astronauts' lymphocytes. , 1996, International Journal of Radiation Biology.
[153] J. Singh,et al. Anakinra for Rheumatoid Arthritis: A Systematic Review , 2009, The Journal of Rheumatology.
[154] Joseph A. DiDonato,et al. An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models , 2008, Science.
[155] Aleksandar Dordević,et al. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats. , 2007, Colloids and surfaces. B, Biointerfaces.
[156] T. Demirkasimoğlu,et al. Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer , 2007, Medical oncology.
[157] J. Swenberg,et al. WR1065 mitigates AZT‐ddI‐induced mutagenesis and inhibits viral replication , 2009, Environmental and molecular mutagenesis.
[158] J. Little,et al. Molecular Events in Radiation Transformation , 2001, Radiation research.
[159] H. Planel,et al. Influence on cell proliferation of background radiation or exposure to very low, chronic gamma radiation. , 1987, Health physics.
[160] James B. Murphy,et al. STUDIES ON X-RAY EFFECTS IX. THE ACTION OF SERUM FROM X-RAYED ANIMALS ON LYMPHOID CELLS IN VITRO. , 1922 .
[161] F. Strutz,et al. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. , 2005, Kidney international.
[162] A. Wennborg,et al. Long-term global gene expression patterns in irradiated human lymphocytes. , 2003, Carcinogenesis.
[163] S. Miscia,et al. Nutlins and ionizing radiation in cancer therapy. , 2010, Current pharmaceutical design.
[164] M. Ferguson,et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies , 2009, The Lancet.
[165] F. Milliat,et al. Pravastatin limits radiation-induced vascular dysfunction in the skin. , 2009, The Journal of investigative dermatology.
[166] P. Vassalli,et al. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis , 1989, The Journal of experimental medicine.
[167] S. Hahn,et al. Tempol, a stable free radical, is a novel murine radiation protector. , 1992, Cancer research.
[168] C. Pui,et al. Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. , 2006, Journal of the National Cancer Institute.
[169] P. Piguet. Cytokines involved in pulmonary fibrosis. , 1993, International review of experimental pathology.
[170] M. Kuroki,et al. PPARalpha ligand WY14643 reduced acute rejection after rat lung transplantation with the upregulation of IL-4, IL-10 and TGFbeta mRNA expression. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[171] A. Marusyk,et al. Irradiation Selects for p53-Deficient Hematopoietic Progenitors , 2010, PLoS biology.
[172] P. Klatt,et al. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. , 2007, Genes & development.
[173] B. Dijkmans,et al. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium , 2007, Annals of the rheumatic diseases.
[174] G. Semenza,et al. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. , 1998, Molecular pharmacology.
[175] Miho Suzuki,et al. Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule , 2009, Rheumatology International.
[176] F. Faraci,et al. Endogenous Interleukin-10 Inhibits Angiotensin II–Induced Vascular Dysfunction , 2009, Hypertension.
[177] Dong-Hoon Shin,et al. A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α , 2008, Molecular Cancer Therapeutics.
[178] A. Harris,et al. Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1α , 2003, Cancer Chemotherapy and Pharmacology.
[179] M. O’Banion,et al. TNFα and IL-1β mediate intercellular adhesion molecule-1 induction via microglia–astrocyte interaction in CNS radiation injury , 1999, Journal of Neuroimmunology.
[180] Zeng-peng Li,et al. Targeting truncated APE1 in mitochondria enhances cell survival after oxidative stress. , 2008, Free radical biology & medicine.
[181] M I Koukourakis,et al. Amifostine in clinical oncology: current use and future applications , 2002, Anti-cancer drugs.
[182] H. Yoshiji,et al. Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138. , 2009, World journal of gastroenterology.
[183] L. Nijtmans,et al. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate. , 1992, Biochemical pharmacology.
[184] H. Yoshiji,et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis , 2003, Gut.
[185] E. Holler,et al. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: interleukin-10 protects against transendothelial migration. , 1997, Transplantation.
[186] D. Berman,et al. The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis , 2003, Circulation.
[187] G. Ming,et al. DNA excision repair proteins and Gadd45 as molecular players for active DNA demethylation , 2009, Cell cycle.
[188] Jian Yu,et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. , 2008, Cell stem cell.
[189] Hans Clevers,et al. The intestinal stem cell. , 2008, Genes & development.
[190] H. Møller,et al. Radiation-induced malignancies following radiotherapy for breast cancer , 2004, British Journal of Cancer.
[191] P. Karran,et al. Vanillins--a novel family of DNA-PK inhibitors. , 2003, Nucleic acids research.
[192] Wafik S El-Deiry,et al. P53 and radiation responses , 2003, Oncogene.
[193] P. Hainaut,et al. Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay , 2001, Oncogene.
[194] T. Nishino,et al. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. , 2004, Kidney international.
[195] Heinrich Leonhardt,et al. Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells , 2007, Nucleic acids research.
[196] K. Ryan,et al. Noradrenaline acting at central β-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration , 2010, Brain, Behavior, and Immunity.
[197] A. Giatromanolaki,et al. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress , 2005, Journal of Clinical Pathology.
[198] S. Mohan,et al. Induced telomerase activity in primary aortic endothelial cells by low-LET gamma-radiation is mediated through NF-kappaB activation. , 2008, The British journal of radiology.
[199] A. Haimovitz-Friedman,et al. Radiation Damage in Endothelial Cells Autocrine Effects of Fibroblast Growth Factor in Repair of Updated , 2006 .
[200] R. Ciccocioppo,et al. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients , 2004, Alimentary pharmacology & therapeutics.
[201] Chunling Zhang,et al. Smad3 Specific Inhibitor, Naringenin, Decreases the Expression of Extracellular Matrix Induced by TGF-β1 in Cultured Rat Hepatic Stellate Cells , 2006, Pharmaceutical Research.
[202] E. Bargagli,et al. Infliximab Treatment in a Patient with Systemic Sclerosis Associated with Lung Fibrosis and Pulmonary Hypertension , 2005, Respiration.
[203] D. Moore,et al. Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. , 2009, The Journal of bone and joint surgery. American volume.
[204] David J Brenner,et al. Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome. , 2003, American journal of human genetics.
[205] P. Kupelian,et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[206] H. Duan,et al. Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage , 2009, Acta Pharmacologica Sinica.
[207] T. Paunesku,et al. Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair , 2009, International journal of radiation biology.
[208] Kevin M. Prise,et al. Radiation-induced bystander signalling in cancer therapy , 2009, Nature Reviews Cancer.
[209] L. Katwa,et al. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. , 2003, Journal of molecular and cellular cardiology.
[210] S. Seal,et al. Phosphate ester hydrolysis of biologically relevant molecules by cerium oxide nanoparticles. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[211] E. Wright,et al. Chromosomal instability in unirradiated hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation. , 2008, Cancer research.
[212] D. Kuter. New thrombopoietic growth factors. , 2009, Clinical lymphoma & myeloma.
[213] D. Murray,et al. Influence of intracellular thiol and polyamine levels on radioprotection by aminothiols. , 1993, International journal of radiation biology.
[214] N. Curtin,et al. Poly(ADP-Ribose) polymerase-1 and DNA-dependent protein kinase have equivalent roles in double strand break repair following ionizing radiation. , 2009, International journal of radiation oncology, biology, physics.
[215] James B. Mitchell,et al. Amelioration of Radiation-induced Fibrosis , 2004, Journal of Biological Chemistry.
[216] G. Woloschak,et al. Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine. , 1997, Carcinogenesis.
[217] Sang-Gu Hwang,et al. Bcl‐XL and STAT3 mediate malignant actions of γ‐irradiation in lung cancer cells , 2010, Cancer science.
[218] A. Dicker,et al. Nuclear factor κB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos , 2009, Molecular Cancer Therapeutics.
[219] J. Damilakis,et al. Therapeutic external irradiation in women of reproductive age: risk estimation of hereditary effects. , 2004, The British journal of radiology.
[220] D. Peterson,et al. ESMO GUIDELINES WORKING GROUP. MANAGEMENT OF ORAL AND GASTROINTESTINAL MUCOSITIS: ESMO CLINICAL PRACTICE GUIDELINES , 2010 .
[221] P. O'Connor,et al. The apoptosis-associated gamma-ray response of BCL-X(L) depends on normal p53 function. , 1996, Oncogene.
[222] I. Basic,et al. Antimutagenic Effects of Radioprotector WR-2721 Against Fission-spectrum Neutrons and 60Co γ-rays in Mice , 1992 .
[223] S. Ledoux,et al. Enhanced mtDNA repair capacity protects pulmonary artery endothelial cells from oxidant-mediated death. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[224] S. Ryter,et al. Mechanisms of cell death in oxidative stress. , 2007, Antioxidants & redox signaling.
[225] R. Snyder,et al. Radiosensitivity of polyamine-depleted HeLa cells and modulation by the aminothiol WR-1065. , 1994, Radiation research.
[226] W. Huda,et al. Effective doses in radiology and diagnostic nuclear medicine: a catalog. , 2008, Radiology.
[227] B. Fanburg,et al. Transforming Growth Factor-β1-induced Activation of the ERK Pathway/Activator Protein-1 in Human Lung Fibroblasts Requires the Autocrine Induction of Basic Fibroblast Growth Factor , 2000 .